Saluda Medical IncASX: SLD

CEO's Address to Shareholders

· Issued by Saluda Medical Inc via ASX

Filed with ASX · · 4 pages · English

Summary by 6ix AI

This filing is an address by Chief Executive Officer Mike Mathias to shareholders at Saluda Medical's annual meeting. The CEO highlighted significant achievements in the past fiscal year, including record revenue growth and increased physician adoption of their Evoke® Therapy. Looking ahead, the company aims to continue expanding physician adoption and improving operational efficiency.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

ASX ANNOUNCEMENT 18 November 2026 Address by Chief Executive Officer Mike Mathias Saluda Medical, Inc. 2026 Annual Meeting – 18 November 2026 Saluda Medical, Inc. (ASX:SLD, “Saluda” or the “Company”) will hold its Annual Meeting today at 11:30AM (AEDT). Attached is a copy of the address...

Saluda Medical Inc on 6ix

Earlier from Saluda Medical

Later from Saluda Medical

All Saluda Medical news releases